PD-L1/PD-1 coexpression with CXCR3/CD36 in circulating lymphocytes was investigated in posttherapy lymphoma patients with extranodal involvement (n = 34) or without extranodal involvement (n = 44) (Figure 1). The gene discussed is CD36; the disease is lymphoma.